4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-027646
Director bought 641 shares at an average $2.61 ($1,673)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Galante Joseph C Director | 2022-04-14 | Purchase | +56 | $2.71 | $152 | 45,117 | D |
| Galante Joseph C Director | 2022-04-18 | Purchase | +56 | $2.63 | $147 | 45,173 | D |
| Galante Joseph C Director | 2022-04-19 | Purchase | +56 | $2.69 | $151 | 45,229 | D |
| Galante Joseph C Director | 2022-04-20 | Purchase | +56 | $2.74 | $153 | 45,285 | D |
| Galante Joseph C Director | 2022-04-21 | Purchase | +56 | $2.75 | $154 | 45,341 | D |
| Galante Joseph C Director | 2022-04-22 | Purchase | +56 | $2.73 | $153 | 45,397 | D |
| Galante Joseph C Director | 2022-04-25 | Purchase | +61 | $2.62 | $160 | 45,458 | D |
| Galante Joseph C Director | 2022-04-26 | Purchase | +61 | $2.53 | $154 | 45,519 | D |
| Galante Joseph C Director | 2022-04-27 | Purchase | +61 | $2.41 | $147 | 45,580 | D |
| Galante Joseph C Director | 2022-04-28 | Purchase | +61 | $2.51 | $153 | 45,641 | D |
| Galante Joseph C Director | 2022-04-29 | Purchase | +61 | $2.44 | $149 | 45,702 | D |
| Open-market purchases · 641 sh · avg $2.61 · $1,673 | |||||||
Loading xslF345X03/doc4.xml…